Journal for ImmunoTherapy of Cancer (Nov 2020)

817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties

  • Anne-Laure Blayo,
  • Laurène Deshons,
  • Alexia Dumont,
  • Christel Franchet,
  • Célia Halter,
  • Ludovic Herbin,
  • Gaël Hommet,
  • Stanislas Mayer,
  • Alban Bessede,
  • Imane Nafia,
  • Marjorie Sidhoum,
  • Xavier Leroy,
  • Stéphan Schann

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0817
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.